Adherence to warfarin treatment among patients with atrial fibrillation-Reference-Cited by-同舟云学术

Adherence to warfarin treatment among patients with atrial fibrillation

Published:2014-07-31 Issue:12 Volume:103 Page:998-1005
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Skeppholm Mika,Friberg Leif

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-014-0742-y.pdf

Reference26 articles.

1. Camm AJ, Lip GY, De Caterina R et al (2012) 2012 focused update of the esc guidelines for the management of atrial fibrillation: An update of the 2010 esc guidelines for the management of atrial fibrillation developed with the special contribution of the european heart rhythm association. Europace 14:1385–1413

2. Aguilar MI, Hart R (2005) Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 3:CD001927

3. Rosendaal FR, Cannegieter SC, van der Meer FJ et al (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–239

4. Connolly SJ, Pogue J, Eikelboom J et al (2008) Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation 118:2029–2037

5. Morgan CL, McEwan P, Tukiendorf A et al (2009) Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res 124:37–41

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation;The American Journal of Medicine;2024-06

2. Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?;Circulation;2024-01-23

3. Lower-adherence direct oral anticoagulant use is associated with increased risk of thromboembolic events than warfarin;Journal of Interventional Cardiac Electrophysiology;2023-08-09

4. Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database;Clinical Therapeutics;2023-04

5. Comparison of the Safety and Efficacy of Warfarin Versus Rivaroxaban in Northern Chinese Patients with Different CHA2DS2-VASc Scores: A Retrospective Cohort Study;Cardiovascular Innovations and Applications;2023